Live Breaking News & Updates on Celltrace Violet|Page 2
Stay updated with breaking news from Celltrace violet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Themis is indispensable for IL-2 and IL-15 signaling in T cells science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
Science for just $15 USD. Short circuiting solid tumors Two major hurdles in chimeric antigen receptor (CAR) T cell therapy for solid tumors are ensuring specificity to tumor cells without affecting healthy cells and avoiding tumor escape due to antigen loss. To address these challenges, Hyrenius-Wittsten et al. and Choe et al. developed synthetic Notch (synNotch)–CAR T cells targeting solid tumor antigens and used them to treat mouse models of mesothelioma, ovarian cancer, and glioblastoma. In both studies, the authors demonstrated that synNotch-CAR T cells were better at controlling tumors than traditional CAR T cells and did not result in toxicity or damage to healthy tissue. These results suggest that synNotch-CAR T cells may be an effective treatment strategy for solid tumors. ....
Expert Insight: CAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma: Your questions answered Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape 15 Dec 2020 Carlos Fernández de Larrea, University of Barcelona and Rogier M. Reijmers, LUMICKS There have been significant advances in the treatment of relapsed multiple myeloma over the past decade, which in turn has resulted in an increase in survival rates. A very promising and novel approach is the application of chimeric antigen receptor (CAR) T cells, which have already demonstrated unprecedented clinical successes in the treatment of pediatric lymphoblastic leukemia. ....